Post by Queen's Park Equity

In this piece, Mark Crowley explores why market access has become a core strategic function in global life sciences, shaping how therapies are developed, priced and ultimately reach patients across markets. This conviction underpinned our recent investment in Initiate, a leading market access and HEOR specialist, and the first investment from QPE Fund II. Initiate’s deep expertise across HTA, pricing, reimbursement and evidence generation reflects the growing importance of specialist capabilities in an increasingly complex global environment. Click below to read more: https://lnkd.in/evS9divb #QPE #marketaccess #HEOR